Literature DB >> 16922653

Generation of human hepatocytes by stem cell technology: definition of the hepatocyte.

Jan G Hengstler1, Marc Brulport, Wiebke Schormann, Alexander Bauer, Matthias Hermes, Andreas K Nussler, Fred Fandrich, Maren Ruhnke, Hendrik Ungefroren, Louise Griffin, Ernesto Bockamp, Franz Oesch, Marc-Alexander von Mach.   

Abstract

Since 1999, numerous articles have reported the generation of hepatocytes from different types of extrahepatic stem or precursor cells. This opens exciting new possibilities for pharmacology and toxicology, as well as for cell therapy. Hepatocyte marker expression, including albumin, cytokeratin 18, c-met, alpha-fetoprotein and cytochrome P450 3A4 and -2B6, has been observed after transplantation of different types of human stem cells into the liver of laboratory animals or in vitro after incubation with cytokines. These intriguing observations have prompted scientists to classify stem cell-derived cell populations as hepatocytes. However, this conclusion may be premature. It has been shown that factors of the liver microenvironment can induce expression of a limited number of hepatocyte marker genes in nonhepatic cell types. To conclude on the grounds of a limited number of markers that these cells are true hepatocytes is not indicated. In this case one should carefully evaluate crucial hepatocyte-defining enzymatic properties. The present article: i) reviews studies describing the fate of extrahepatic human stem and precursor cells in livers of laboratory animals, including the possibility of cell fusion; and ii) critically discusses the phenotype of stem cells after application of various differentiation protocols aimed at generating human hepatocytes. In addition, the necessary criteria needed for defining a true hepatocyte are suggested. Establishing the necessary properties for stem cell-derived hepatocytes is timely and reasonable, and thus avoids further misleading semantic confusion. Finally, it is essential to understand that the definition of a bona fide hepatocyte should not be limited to qualitative assays, such as reverse transcriptase polymerase chain reaction and immunohistochemistry, but has to include a quantitative analysis of enzymatic activities, which allows direct comparison with primary hepatocytes. Although the stem cell-derived-hepatocyte does not yet exist there is a good chance that this aim may be achieved in the future.

Entities:  

Mesh:

Year:  2005        PMID: 16922653     DOI: 10.1517/17425255.1.1.61

Source DB:  PubMed          Journal:  Expert Opin Drug Metab Toxicol        ISSN: 1742-5255            Impact factor:   4.481


  29 in total

Review 1.  Stem cells for liver tissue repair: current knowledge and perspectives.

Authors:  Philippe A Lysy; David Campard; Françoise Smets; Mustapha Najimi; Etienne M Sokal
Journal:  World J Gastroenterol       Date:  2008-02-14       Impact factor: 5.742

2.  Persistence of a chimerical phenotype after hepatocyte differentiation of human bone marrow mesenchymal stem cells.

Authors:  P A Lysy; D Campard; F Smets; J Malaise; M Mourad; M Najimi; E M Sokal
Journal:  Cell Prolif       Date:  2008-02       Impact factor: 6.831

Review 3.  The possible use of stem cells in regenerative medicine: dream or reality?

Authors:  Sabrina Ehnert; Matthias Glanemann; Andreas Schmitt; Stephan Vogt; Naama Shanny; Natascha C Nussler; Ulrich Stöckle; Andreas Nussler
Journal:  Langenbecks Arch Surg       Date:  2009-07-31       Impact factor: 3.445

4.  Aggregate culture of human embryonic stem cell-derived hepatocytes in suspension are an improved in vitro model for drug metabolism and toxicity testing.

Authors:  Srikumar Sengupta; Brian Patrick Johnson; Scott Allen Swanson; Ron Stewart; Christopher Alan Bradfield; James Alexander Thomson
Journal:  Toxicol Sci       Date:  2014-04-20       Impact factor: 4.849

Review 5.  Multipotent mesenchymal stromal cells: A promising strategy to manage alcoholic liver disease.

Authors:  Fernando Ezquer; Flavia Bruna; Sebastián Calligaris; Paulette Conget; Marcelo Ezquer
Journal:  World J Gastroenterol       Date:  2016-01-07       Impact factor: 5.742

Review 6.  Concise Review: Updated Advances and Current Challenges in Cell Therapy for Inborn Liver Metabolic Defects.

Authors:  Mustapha Najimi; Florence Defresne; Etienne M Sokal
Journal:  Stem Cells Transl Med       Date:  2016-05-31       Impact factor: 6.940

Review 7.  Hepatocyte-like cells derived from induced pluripotent stem cells.

Authors:  Namita Roy-Chowdhury; Xia Wang; Chandan Guha; Jayanta Roy-Chowdhury
Journal:  Hepatol Int       Date:  2016-08-17       Impact factor: 6.047

Review 8.  Liver cell transplantation for Crigler-Najjar syndrome type I: update and perspectives.

Authors:  Philippe-A Lysy; Mustapha Najimi; Xavier Stephenne; Annick Bourgois; Francoise Smets; Etienne-M Sokal
Journal:  World J Gastroenterol       Date:  2008-06-14       Impact factor: 5.742

9.  New Strategies for Acute Liver Failure: Focus on Xenotransplantation Therapy.

Authors:  Luiz Anastácio Alves; André Bonavita; Kátia Quaresma; Elenilde Torres; Paulo Anastácio Furtado Pacheco; Vinícius Cotta-de-Almeida; Roberto Magalhães Saraiva
Journal:  Cell Med       Date:  2010-07-01

Review 10.  In vitro differentiation of embryonic and adult stem cells into hepatocytes: state of the art.

Authors:  Sarah Snykers; Joery De Kock; Vera Rogiers; Tamara Vanhaecke
Journal:  Stem Cells       Date:  2009-03       Impact factor: 6.277

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.